- Home
- AADX vs VKTX Comparison
AADX vs VKTX Comparison
Compare AADX & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AADX | VKTX |
|---|---|---|
| Founded | N/A | 2012 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | 2026 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AADX | VKTX |
|---|---|---|
| Price | $23.08 | $38.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $95.86 |
| AVG Volume (30 Days) | 1.3M | ★ 2.9M |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.28 | $22.96 |
| 52 Week High | $24.24 | $43.15 |
Technical Indicators
Market Signals| Indicator | AADX | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 84.08 | 67.73 |
| Support Level | $17.28 | $32.66 |
| Resistance Level | $24.24 | $39.78 |
| Average True Range (ATR) | 1.64 | 2.23 |
| MACD | 0.54 | 0.63 |
| Stochastic Oscillator | 80.24 | 74.84 |
Price Performance
Historical ComparisonAbout AADX Applied Aerospace & Defense Inc. Common Stock
Applied Aerospace & Defense Inc specializes in providing engineering and vertically integrated manufacturing solutions for space and defense technology companies. The company builds complex hardware for extreme operating environments, combining deep material science and IP-enabled process expertise with the ability to enable rapid prototyping, enhance new product development, and responsively scale production. The majority of the company's revenue is derived from the sales of Defense Aviation and Airborne Systems, followed by Space and Launch Systems, C5ISR and Precision Strike Systems.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.